Akari Therapeutics, Plc (AKTX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | 8-K (2025-05-15) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-04-16) · 99.1 | ||
| 10-K | FY-2024 | — | ||
| 10-Q | Q3-2024 | — | ||
| 10-Q | Q2-2024 | 8-K (2024-08-19) · 99.1 | 8-K (2024-05-16) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-04-01) · 99.1 | ||
| 10-K | FY-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Operations and Comprehensive (loss) Income | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Condensed Consolidated Statements of Changes In Shareholders' Equity (unaudited) | — |
|
| Consolidated Statements of Changes In Shareholders' Equity (deficit) | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Changes In Shareholders' Equity (deficit) (P) | ||
| Notes | ||
| Accrued Expenses | ||
| Agreement and Plan of Merger | ||
| Award Timing Disclosure | — |
|
| Commitments and Contingencies | ||
| Convertible Notes and Notes Payable | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Description of Business | ||
| Fair Value Measurements | ||
| Goodwill and Intangible Assets | — |
|
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Intangible Assets | ||
| Net Loss Per Share | — |
|
| Pay Vs Performance Disclosure | ||
| Peak Bio Acquisition | — |
|
| Related Party Transactions | ||
| Restructuring | — |
|
| Segment Information | ||
| Shareholders Equity | ||
| Shareholders' (deficit) Equity | ||
| Shareholders' Equity (deficit) | ||
| Stock-based Compensation | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||